Collegium Pharmaceutical Inc
COLL
Market Cap$1.22B
Close$
$17.40
55.6% downside
Current Fair Value
55.6% downsideOvervalued by 55.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.22 Billion |
|---|---|
| Enterprise Value | $1.94 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.14 |
| Beta | 0.68 |
| Outstanding Shares | 31,810,612 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 34.03 |
|---|---|
| PEG | -87.52 |
| Price to Sales | 1.78 |
| Price to Book Ratio | 5.6 |
| Enterprise Value to Revenue | 2.75 |
| Enterprise Value to EBIT | 14.27 |
| Enterprise Value to Net Income | 53 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 3.61 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Collegium Pharmaceutical Inc
CEO: Joseph Ciaffoni